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Abstract
Acute kidney injury (AKI) is a common clinical syndrome with a broad aetiological proﬁ le. 
It complicates about  of hospital admissions and  of admissions to intensive care units 
(ICU). During last  years has been a signiﬁ cant change in the spectrum of severe AKI such 
that it is no longer mostly a single organ phenomenon but rather a complex multisystem clinical 
problem. Despite great advances in renal replacement technique (RRT), mortality from AKI, 
when part of MOF, remains over . 
] e changing nature of AKI requires a new approach using the new advanced technology. 
Clinicians can provide therapies tailored to time constraints (intermittent, continuous, or ex-
tended intermittent), haemodynamic, and metabolic requirements and aimed at molecules of 
variable molecular weight. 
Peritoneal dialysis (PD) is technically the simplest form of RRT and is still commonly used 
worldwide. ] e problems include diﬃ  culty in maintaining dialysate ﬂ ow, peritoneal infection, 
leakage, protein losses, and restricted ability to clear ﬂ uid and uraemic wastes. PD is the pre-
ferred treatment modality for AKI in pediatric practice. Patients that are hemodynamically 
stable can be managed with intermittent hemodyalisis (IHD), whereby relatively short ( to 
 h) dialysis sessions may be performed every day or every other day. Patients who are haemo-
dynamically unstable are best managed using continuous renal replacement therapies (CRRT), 
which allow for continuous ﬁ ne-tuning of intravascular volume, easier correction of hypervol-
emia, better solute removal, more accurately correction of metabolic acidosis, and oﬀ ers pos-
sibilities for unlimited energy support. Recently, “hybrid” or sustained low-eﬃ  ciency dialysis 
(SLED) was introduced as a method which combines the advantages of IHD with those of 
CRRT. In this technique, classic dialysis hardware is used at low blood and dialysate ﬂ ow rates, 
for prolonged period of time ( to  h/day). SLED oﬀ ers more haemodynamic stability, better 
correstion of hypervolaemia, and more adequate solue removal, compared with IHD. 
In conclusion, AKI in the ICU is increasingly a component of sepsis and MSOF, and the devel-
opment of rational strategies for initiation, dosing, and eﬀ ective delivery of RRT in this setting is 
among the greatest challenges facing nephrologists and intensivists today.
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Introduction
Acute kidney injury (AKI) is deﬁ ned as deterioration of 
renal function over hours, days to weeks. ] e mortality 
rate of AKI is -  in intensive care unit (ICU) pa-
tients, and has not declined signiﬁ cantly since the initial 
marked beneﬁ t of acute dialysis therapy. Although mul-
tiple system organ failure (MSOF) and other comorbidi-
ties contribute to its high mortality rate, AKI indepen-
dently increases morbidity and mortality. AKI-speciﬁ c 
severity of illness scoring systems have been validated 
to predict prognosis in ICU AKI, accounting for both 
severity of renal failure and associated MSOF (,). A 
prospective multicenter ICU study of AKI found that 
subjects with septic AKI had a far higher mortality rate 
( vs , p < .) than those without sepsis (). 
Septic AKI is the dominant problem in managing ICU 
patients requiring renal replacement therapy (RRT) (). 
When should RRT be started? 
A number of the indications for RRT are uncontro-
versial, including uremic symptoms (anorexia, nausea, 
vomiting) or signs (bleeding, encephalopathy, uremic 
pericarditis), hyperkalemia refractory to medical man-
agement, volume overload unresponsive to ﬂ uid restric-
tion and diuretics, metabolic acidosis that is severe or 
accompanied by volume overload (precluding adequate 
bicarbonate therapy), certain dialyzable intoxications 
(e.g., lithium, salicylate, toxic alcohols), some cases of 
hypocalcemia, hyperphosphatemia, or hypercalcemia, 
and anuric AKI unresponsive to acute interventions 
(reversal of prerenal factors or relief of obstruction). 
Modern practice is to initiate RRT sooner rather than 
later, for example, when the SCr concentration reaches 
– μmol/l, perhaps even earlier, unless there is 
clear evidence that renal function is about to recover (). 
Institution of RRT
The choice of the treatment will depend on the clini-
cal practice, technical resources, and well-trained 
nurses of a given department, than on precise clini-
cal indication. A proficient and accountable team, 
experienced in various dialytic modalities with a 
quality assurance education program would be ide-
al (). If this is not possible, the best combination of 
simple and easy treatment schedules, which are func-
tional and efficient with no significant increases in 
personnel demand or labour intensity must suffice. 
Biocompatibility
Two major studies found that use of biocompat-
ible membranes improved these outcomes in AKI 
(,). Several subsequent studies have failed to con-
ﬁ rm the beneﬁ ts of biocompatibility in AKI, but have 
lacked the statistical power to deﬁ nitively exclude any 
eﬀ ect (). Use of a biocompatible dialyzer that also has 
higher “ﬂ ux” (permeability) than the bioincompatible 
dialyzer may have inﬂ uenced outcome in one study (). 
In light of a number of conﬂ icting studies, the clinical 
relevance of this aspect of the acute dialysis prescrip-
tion remains unproven, despite the fact that this strat-
egy has already become standard in many centers (). 
Dose of dialysis
] e lack of a standardized measurement of RRT dose in 
AKI is a major deﬁ ciency in the ﬁ eld. Clearance of urea 
is the most commonly studied marker of adequate ure-
mic detoxiﬁ cation by IHD. ] e term Kt/V is a measure 
of the volume of plasma cleared of urea during an HD 
session (Kt) divided by the urea distribution volume (V, 
assumed to be total body water: .-. L/kg). ] e larger 
Kt/V values signify greater HD dose. Until further data 
is available, a reasonable recommendation oﬀ ered by 
the Acute Dialysis Quality Initiative is to deliver a dose 
of HD in the acute setting that is at least equal to what 
is considered acceptable in the chronic end-stage renal 
disease (ESRD) population. ] is is a Kt/V >. per treat-
ment if IHD is provided three-times per week. Alterna-
tively, one can attempt to deliver a Kt/V >. per treat-
ment on a dialysis schedule of at least six days a week. 
Paganini et al.() demonstrated by retrospective analysis 
of a prospectively gathered database that delivered di-
alysis dose was predictive of mortality in critically ill ARI 
patients treated with RRT, if they had moderate-range 
severity of illness, but mortality of the most and least 
severely ill patients was independent of dialysis dose . 
Choice of RRT
There are now many available options of RRT which 
may be divided into  groups: . peritoneal dialysis 
(PD), . IHD, . continuous therapies (CRRT), and 
. hybrid therapies (SLED). The ideal RRT should 
mimic the functions and physiological mechanisms 
of the native organ, ensuring qualitative and quantita-
tive blood puriﬁ cation, be free of complications, have 
good clinical tolerance and restore and maintain ho-
meostasis, thus favouring organ recovery (Table ). 
These  groups of RRT differ in the method of deliv-
ery, eﬃ  ciency, and their clinical tolerability. ] ere are 
certain clinical situations in which only a particular 
therapy is indicated (e.g., CRRT in critically ill patients 
with cardiovascular instability) (). Distinguishing 
whether AKI is a result of single organ dysfunction 
or part of MOF is a key factor. These two groups of 
subjects diﬀ er substantially and should be treated dif-
ferently. AKI without MOF is less complex, can be 
managed outside ICU and the same RRT techniques 
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used for the treatment of chronic renal failure may 
be applied. AKI associated with MOF is a more com-
plex condition and requires more ﬂ exible RRT (,). 
Peritoneal dialysis
Acute PD remains a viable option for the treatment of 
selected patients with AKI, particularly pediatric popu-
lation, and those who are hemodynamically compro-
mised, have severe coagulation abnormalities, diﬃ  culty 
in obtaining blood access, removal of high molecular 
weight toxins (> kD), and clinically signiﬁ cant hypo-
thermia and hyperthermia. ] ere are very few absolute 
contraindications for acute PD, most of the following 
conditions are only relative contraindications to this 
modality (). One of the important determinants of a 
successful acute PD procedure is a reliable peritoneal 
access, which can easily be obtained by inserting a semi-
rigid acute catheter or a single cuﬀ  Tenckhoﬀ  catheter. 
Acute PD can be performed intermittently or continu-
ously, and either manually or via an automated device. 
Complications of acute PD are numerous and poten-
tially serious, but preventable, and include peritonitis, 
hyperglycemia, substantial protein loss, disturbance of 
respiratory mechanics, and visceral perforation while 
inserting the catheter (). Most studies have shown 
that the mortality and incidence of renal recovery 
with acute PD was at least comparable to IHD (,). 
Intermittent hemodialysis
] ese technique require good vascular access, special 
equipment and specially trained physicians and nurses 
to carry out the dialysis. Patients that are hemody-
namically stable can be managed with IHD techniques. 
Maintaining hemodynamic stability is probably one 
of the most important aspects of dialysis technique as 
well as one of the most diﬃ  cult challenges. To improve 
hemodynamic tolerance of IHD, specific guidelines 
were implemented into practice (Table ). ] e practice 
guidelines are based on dialysis strategies experienced 
in chronic HD patients suﬀ ering from cardiovascular 
insuﬃ  ciency. However, the targets for adequate solute 
clearance in AKI remain unknown, and the impor-
tance of removing middle and large uremic toxins in 
the setting of AKI remains to be determined. Conse-
quently, physicians should consider empirical increas-
es in dialytic time and IHD frequency and judicious 
use of anticoagulation to improve dialysis adequacy.
Continuous renal replacement therapies
With CRRT, the continuous regulation of volume ho-
meostasis could lessen the hourly rate of required UF, 
thereby improving hemodynamic stability compared 
with IHD. Control of azotemia with modern veno-ve-
nous CRRT is at least equivalent to alternate-day IHD, 
and superior to daily IHD in large or hypercatabolic pa-
tients. Clinical data suggest that CRRT should be strong-
ly considered for patients with severe hyperphosphate-
mia (tumor lysis syndrome, rhabdomyolysis), elevated 
intracranial pressure (ICP), cerebral edema complicat-
ing acute liver failure, might be a useful component of 
therapy for lithium intoxication, and because of con-
tinuous nature of process prevents the post-dialytic 
“rebound” elevation of plasma concentration of uremic 
toxins typically seen with IHD. ] e clinical beneﬁ ts of 
CRRT have also been reported for cardiac surgery pa-
tients. CRRT appears to have beneﬁ cial eﬀ ects on he-
modynamics in SIRS, sepsis or septic shock (Figure ). 
Although much attention has been focused on per-
ceived benefits of CRRT compared with IHD, com-
paratively less attention has been focused on the po-
tential for increased risks with CRRT therapy (Table 
). In AKI patients stable enough to tolerate IHD, this 
benefit should be balanced against aspects of CRRT 
that might adversely aﬀ ect outcome, such as continu-
ous anticoagulation, prolonged membrane exposure, 
hypothermia, and nonselective removal of nutrients, 
inﬂ ammatory mediators, and drugs. Despite apparent 
advantages over IHD in unstable patients, superior-
ity of CRRT with respect to mortality or recovery of 
renal function has not been demonstrated. In patients 
Rapid and easy institution with simple treatment monitoring 
Eﬃ  ciency and eﬃ  cacy which satisﬁ es therapy prescription 
Volume control without causing cardiovascular instability 
Allows ﬂ uid administration/nutrition maintaining euvolemia 
Maintains stable acid–base balance 
High biocompatibility with minimal interaction with blood 
Clinical tolerance 
No deleterious eﬀ ects on renal function or duration of acute renal failure 
Easy and predictable adjustment of drug dosing 
Inexpensive 
Recommendations for systematic use:
 - Use only modiﬁ ed cellulosic or synthetic membranes in place 
 of cuprophane
 - Connect simultaneously both lines of the circuit ﬁ lled with 
 0.9% saline to the central venous catheter
 - Set dialysate sodium concentration ≥ 145 mmol/l 
 - Limit the maximal blood ﬂ ow at 150 ml/min with a minimal 
 session duration of 4 hour
 - Set dialysate temperature ≤ 37° C
Advice for the most hemodynamically unstable patients:
 - Start session by dialysis and continue with UF alone
 - Cool dialysate at 35° C
Additional recommendations:
 - Stop vasodilator therapy
TABLE 1. Technical and clinical requirements for an optimal renal 
replacement therapy in acute renal injury
TABLE 2. Intermittent hemodialysis practice quidelines
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stable enough to tolerate IHD, this beneﬁ t should be 
balanced against aspects of CRRT that might adversely 
affect outcome. IHD and CRRT should be regarded 
as complementary techniques, which should both be 
available in institutions that care for critically ill pa-
tients, allowing RRT to be individualized to the needs 
of the complex patients who develop AKI in the ICU. 
AKI in the ICU patients is increasingly a component of 
SIRS, sepsis or septic shock, and the development of ra-
tional strategies for initiation, dosing, and eﬀ ective de-
livery of RRT in this setting is among the greatest chal-
lenges facing nephrologists and intensivists today (). 
The use of CRRT is increasing in children and even 
newborns, and includes several modalities (CVVH, CV-
VHD, and CVVHDF). In patients treated with CRRT, 
the rate of fluid and solute removal is slow and con-
tinuous. As a result, CRRT is better tolerated than IHD 
in patients who are hemodynamically unstable. The 
removal of solutes over the course of  to  hours 
is as efficient as conventional hemodialysis. In addi-
tion, some prefer this technique in patients with sepsis 
or MOF, as it may enhance the removal of cytokines.
‘Hybrid’ renal replacement therapies
] is technique utilizes equipmen t originally developed 
for treatment of patients with chronic renal failure and 
does not require industrially produced substitution ﬂ uid. 
] e term “sustained low-eﬃ  ciency dialysis” (SLED) is 
the most widely used. ] is means of RRT combines sev-
eral advantages of both IHD and CRRT, most notably 
excellent detoxiﬁ cation and cardiovascular tolerability 
akin to that associated with CVVH. Machines for hy-
brid therapy should ideally have the characteristics like 
flexible options for dialysate flow (QD) (allowing for 
low ﬂ ows should the clinical situation mandate low sol-
ute clearance and UFR), ﬂ exible options for hybrid treat-
ment duration (allowing prolonged or even continuous 
treatments), clear interface with the nurse managing 
the treatment preferably via a dedicated hybrid therapy 
screen, and standard procedures for changing between 
IHD and hybrid therapy (allowing either modality to 
be conveniently chosen at treatment commencement 
without any resultant delay) () (Figure ). Different 
combinations of dry and liquid concentrates can be 
mixed allowing treatments to be tailored to the needs 
of individual patients. ] e extremely ﬂ exible, yet highly 
efficient, SLED treatment modality fulfills all ICU re-
quirements: it oﬀ ers immediate, highly eﬀ ective dialysis 
therapy for acute hyperkalemia, whereas for less-urgent 
indications, treatment durations can be extended up to 
 h. Sustained low-eﬃ  ciency dialysis oﬀ ers several ad-
vantages over CRRT, including less cumbersome tech-
nique, patient mobility, and decreased requirements for 
Intermittent hemodialysis
        Advantages
• Short duration makes more time available for diagnostic and 
therapeutic procedure
• Lower risk of systemic bleeding as a result of less heparin use
• Periodic solute control with subsequent disequilibrium 
• Optional online bicarbonate dialysate production
• Less labor-intensive and therefore less expensive
        Disadvantages 
• Technically sophisticated requiring speciﬁ c infrastructure 
• Qualiﬁ ed dialysis staﬀ  required to supervise the procedure 
• More suitable for severe hyperkalemia 
• Optional online bicarbonate dialysate production
• Dialysis dose and nutritional support might be inadequate at low 
treatment frequencies
• Frequent hypotensive episodes with aggressive UF
Continuous renal replacement therapy
        Advantages
• Machines are generally easy to operate and do not require speciﬁ c 
infrastructure
• Intensive care unit staﬀ  can operate machines and perform 
monitoring
• Prolonged gradual solute and volume removal achieves superior 
solute and ﬂ uid control 
• UF over a longer period provides better hemodynamic stability 
• Adequate nutritional support possible
        Disadvantages
• Higher requirement for heparin and higher risk of systemic bleed-
ing 
• Impairs mobilization of patients
• Treatment frequently interrupted due to ﬁ lter problems, and 
diagnostic and therapeutic procedures
• Expensive sterile substitution solutions substantially increase 
treatment costs
TABLE 3. Comparison of intermittent and continuous renal replace-
ment therapy
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anticoagulation, while providing similar hemodynamic 
stability and volume control. Several economic evalua-
tions have shown SLED to be less expensive than CRRT. 
The Genius system consists of a single-pass batch di-
alysis machine that provides up to  L of an ultrapure 
germ- and endotoxin-free pure bicarbonate dialysate 
per dialysis session and a station for automated pro-
duction of dialysate and filling of the machine. The 
technically simple machine has one roller pump in 
which both blood and dialysate tubing is inserted 
and that pumps blood and dialysate countercurrently 
with a ratio ﬁ xed at : or :, depending on the diam-
eter of the blood and dialysis tubing used. ] us, blood 
ﬂ ow determines duration of treatment, ie, the time in 
which the  L dialysate tank is used up. Treatment 
time can be varied simply by changing the speed of the 
blood pump from  hours (conventional IHD with a 
: system and blood ﬂ ow of  mL/min) to as much 
as  hours (extended dialysis with a : system and 
blood ﬂ ow of  mL/min). ] e blood ﬂ ow and treat-
ment time may be modiﬁ ed within treatment session.
# e impact of dialytic modality on mortality and re-
nal recovery
Currently, it has been found no diﬀ erence in mortality 
or renal recovery between hybrid RRT, CRRT or IHD 
for critically ill patients with AKI. However, future in-
vestigations should collect detailed information on 
long-term costs and the relative likelihood of renal re-
covery associated with dialysis modality. Until informa-
tion from such a trial is available, a systematic review 
such as this may constitute the best possible evidence
List of Abbreviations 
AKI  - acute kidney injury
ICU - intensive care unit
PD - peritoneal dialysis
IH - intermittent hemodialysis
CRRT - continuous renal replacement therapy
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